Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Dow
Federal Trade Commission
Baxter
UBS
Chubb
Argus Health
US Department of Justice
Johnson and Johnson

Generated: December 12, 2017

DrugPatentWatch Database Preview

Sumatriptan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sumatriptan and what is the scope of sumatriptan freedom to operate?

Sumatriptan
is the generic ingredient in nine branded drugs marketed by Glaxosmithkline, Lannett, Meridian Medcl, Antares Pharma Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Injectalia, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sagent Agila, Sagent Strides, Sandoz Inc, Sun Pharma Global, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Endo Ventures Ltd, Avanir Pharms, Dr Reddys Labs Ltd, Teva Branded Pharm, Apotex Inc, Aurobindo Pharma, Hikma Pharms, Mylan, Orchid Hlthcare, Roxane, Sandoz, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs, and is included in forty-one NDAs. There are thirty-six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for sumatriptan. Four suppliers are listed for this compound. There are seven tentative approvals for this compound.

Medical Subject Heading (MeSH) Categories for sumatriptan

Tentative approvals for SUMATRIPTAN

Applicant Application No. Strength Dosage Form
u► SubscribeEQ 25MG BASETABLET;ORAL
u► SubscribeEQ 100MG BASETABLET;ORAL
u► SubscribeEQ 50MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Avanir PharmsONZETRA XSAILsumatriptan succinatePOWDER;INHALATION206099-001Jan 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
RoxaneSUMATRIPTAN SUCCINATEsumatriptan succinateTABLET;ORAL078241-002Aug 10, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Meridian MedclALSUMAsumatriptan succinateINJECTABLE;SUBCUTANEOUS022377-001Jun 29, 2010DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
TevaSUMATRIPTAN SUCCINATEsumatriptan succinateTABLET;ORAL076840-001Feb 9, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sagent StridesSUMATRIPTAN SUCCINATEsumatriptan succinateINJECTABLE;SUBCUTANEOUS090314-001Jun 10, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Avanir PharmsONZETRA XSAILsumatriptan succinatePOWDER;INHALATION206099-001Jan 27, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Aurobindo PharmaSUMATRIPTAN SUCCINATEsumatriptan succinateTABLET;ORAL078327-001Aug 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Endo Ventures LtdSUMAVEL DOSEPROsumatriptan succinateINJECTABLE;SUBCUTANEOUS022239-001Jul 15, 2009BXRXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-002Aug 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
RoxaneSUMATRIPTAN SUCCINATEsumatriptan succinateTABLET;ORAL078241-001Aug 10, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sumatriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-001Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-001Aug 26, 1997► Subscribe► Subscribe
GlaxosmithklineIMITREXsumatriptanSPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
US Army
Farmers Insurance
Mallinckrodt
Express Scripts
Moodys
Teva
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot